Investor profile
Invesco Perpetual has backed 4 European tech companies across 5 funding rounds between 2010 and 2018, joining rounds totalling €149M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Cell Medica | UK | 1 | €64M |
| Oxford Nanopore Technologies | UK | 2 | €49M |
| Genomics | UK | 1 | €28M |
| Oxford Genetics | UK | 1 | €8.1M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Cell Medica | Series B | €64M | 2014-11 |
| Oxford Nanopore Technologies | Series D+ | €28M | 2011-04 |
| Genomics | Series B | €28M | 2018-09 |
| Oxford Nanopore Technologies |
| Series C |
| €21M |
| 2010-04 |
| Oxford Genetics | Other | €8.1M | 2017-08 |
